Lumizyme



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 40.1%
Glycogen Storage Disease Type Ii 33.8%
Premedication 17.5%
Pain 1.2%
Anxiety 0.9%
Depression 0.7%
Migraine 0.7%
Contraception 0.5%
Fabry's Disease 0.5%
Headache 0.5%
Hypertension 0.5%
Multiple Allergies 0.5%
Rhinorrhoea 0.5%
Constipation 0.4%
Cough 0.4%
Gastrooesophageal Reflux Disease 0.4%
Medical Diet 0.4%
Arthralgia 0.2%
Back Pain 0.2%
Blood Cholesterol Increased 0.2%
Hospitalisation 10.3%
Fall 9.0%
Death 7.7%
Pain 6.4%
Pneumothorax 6.4%
Femur Fracture 5.1%
Infection 5.1%
Myocardial Infarction 5.1%
Dyspnoea 3.8%
Fatigue 3.8%
Neoplasm Malignant 3.8%
Paraesthesia 3.8%
Respiratory Failure 3.8%
Serum Sickness 3.8%
Skin Lesion 3.8%
Small Intestinal Obstruction 3.8%
Therapeutic Response Decreased 3.8%
Urticaria 3.8%
Weight Decreased 3.8%
Abnormal Behaviour 2.6%
Secondary
Premedication 33.1%
Product Used For Unknown Indication 30.6%
Glycogen Storage Disease Type Ii 25.0%
Anxiety 3.2%
Migraine 3.2%
Blood Pressure 2.4%
Pain 2.4%
Local Swelling 15.0%
Paraesthesia 15.0%
Skin Lesion 15.0%
C-reactive Protein Increased 5.0%
Fall 5.0%
Fatigue 5.0%
Hip Fracture 5.0%
Muscle Spasms 5.0%
Pain 5.0%
Pain In Extremity 5.0%
Pneumonia 5.0%
Presyncope 5.0%
Sepsis 5.0%
Serum Sickness 5.0%
Concomitant
Weight Decreased 33.3%
Anxiety 16.7%
Depression 16.7%
Enzyme Abnormality 16.7%
Hypertension 16.7%
Hunger 100.0%